Skip to content

Author

Y. Ting

We have 1 of 14 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Jul 2026

The future of TCR-Treg therapies is renewables.

This review highlights emerging solutions for closed, automated and decentralised production, and discusses allogeneic approaches using gene-edited or banked Tregs with HLA engineering or matching with potential to provide safe, affordable tolerance-restoring therapies for autoimmune disease.

Cheng Rui Peh, T. Nguyen-Dumont, Y. Ting et al. · 2 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.